Del Carmen Jeffrey
Chief Commercial Officer at CPRX
- Sold, on record
- $4.6M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Nov 26, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CPRXCATALYST PHARMACEUTICALS, INC.Chief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CPRXUnusualNov 11, 2022 2022
Sold 139,017 shares at $16.12 ($2.2M)
Del Carmen Jeffrey, Chief Commercial Officer
Sold 100% of holdings ($2.2M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale CPRXUnusualMar 29, 2023 +138 days
Sold 40,000 shares at $16.70 ($668k)
Del Carmen Jeffrey, Chief Commercial Officer
No 10b5-1 planSold 84.1% of holdings ($794k position)7,541 shares leftFiling
- 3 Form 144 notice CPRXNoticeJun 7, 2024 +436 days
Filed to sell 7,541 shares ($121k)
Del Carmen Jeffrey, Officer
No 10b5-1 planFiling
- 4 Form 4 sale CPRXUnusualJun 7, 2024 same day
Sold 7,541 shares at $16.07 ($121k)
Del Carmen Jeffrey, Chief Commercial Officer
No 10b5-1 planSold 29% of holdings ($417k position)18,427 shares leftFollows a Form 144Filing
- 5 Form 144 notice CPRXNoticeAug 9, 2024 +63 days
Filed to sell 36,058 shares ($664k)
Del Carmen Jeffrey, Officer
No 10b5-1 plan0.9x usual sizeFiling
- 6 Form 4 sale CPRXUnusualAug 9, 2024 same day
Sold 36,058 shares at $18.42 ($664k)
Del Carmen Jeffrey, Chief Commercial Officer
No 10b5-1 planSold 74.5% of holdings ($892k position)12,369 shares left0.9x usual sizeFollows a Form 144Filing
- 7 Form 4 sale CPRXUnusualMar 3, 2025 +206 days
Sold 30,423 shares at $22.89 ($696k)
Del Carmen Jeffrey, Chief Commercial Officer
No 10b5-1 planSold 100% of holdings ($696k position)0 shares left0.8x usual sizeFiling
- 8 Form 4 sale CPRXUnusualNov 26, 2025 +268 days
Sold 10,983 shares at $23.33 ($256k)
Del Carmen Jeffrey, Chief Commercial Officer
No 10b5-1 planSold 73.5% of holdings ($349k position)3,962 shares left0.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Nov 28, 2025 | CPRX | Chief Commercial Officer | Form 4 sale | 10,983 | $256k | 73.5% | Unusual | SEC |
| Mar 3, 2025 | Mar 5, 2025 | CPRX | Chief Commercial Officer | Form 4 sale | 30,423 | $696k | 100.0% | Unusual | SEC |
| Aug 9, 2024 | Aug 13, 2024 | CPRX | Chief Commercial Officer | Form 4 sale | 36,058 | $664k | 74.5% | Unusual | SEC |
| Aug 9, 2024 | Aug 9, 2024 | CPRX | Officer | Form 144 notice | 36,058 | $664k | Notice | SEC | |
| Jun 7, 2024 | Jun 11, 2024 | CPRX | Chief Commercial Officer | Form 4 sale | 7,541 | $121k | 29.0% | Unusual | SEC |
| Jun 7, 2024 | Jun 7, 2024 | CPRX | Officer | Form 144 notice | 7,541 | $121k | Notice | SEC | |
| Mar 29, 2023 | Mar 30, 2023 | CPRX | Chief Commercial Officer | Form 4 sale | 40,000 | $668k | 84.1% | Unusual | SEC |
| Nov 11, 2022 | Nov 15, 2022 | CPRX | Chief Commercial Officer | Form 4 sale | 139,017 | $2.2M | 100.0% | Unusual | SEC |